ESR1 and breast carcinoma: MCF-7TamR cells are a subvariant of MCF-7 cells that have developed resistance to the anti-estrogen tamoxifen, a commonly used hormone therapy to treat ER+ breast cancer, and show increased invasion capacity, CSC content and tumorigenicity [36,37].